GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (FRA:L74) » Definitions » YoY Rev. per Sh. Growth

WuXi XDC Cayman (FRA:L74) YoY Rev. per Sh. Growth : 266.67% (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. WuXi XDC Cayman's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2023 was 266.67%.

WuXi XDC Cayman's Revenue per Share for the three months ended in Jun. 2023 was €0.06.

WuXi XDC Cayman YoY Rev. per Sh. Growth Historical Data

The historical data trend for WuXi XDC Cayman's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman YoY Rev. per Sh. Growth Chart

WuXi XDC Cayman Annual Data
Trend Dec20 Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
- 270.00 208.11 121.93

WuXi XDC Cayman Quarterly Data
Dec20 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23
YoY Rev. per Sh. Growth Get a 7-Day Free Trial - - - 266.67 -100.00

WuXi XDC Cayman YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

WuXi XDC Cayman's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(0.253-0.114)/ | 0.114 |
=121.93 %

WuXi XDC Cayman's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2023 is calculated as:

YoY Rev. per Sh. Growth (Q: Jun. 2023 )
=(Revenue per Share (Q: Jun. 2023 )-Revenue per Share (Q: Mar. 2022 )) / | Revenue per Share (Q: Mar. 2022 )) |
=(0.055-0.015)/ | 0.015 |
=266.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WuXi XDC Cayman YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of WuXi XDC Cayman's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi XDC Cayman (FRA:L74) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (FRA:L74) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
Traded in Other Exchanges
02268:Hong Kong
Address
No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN
Website
WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.

WuXi XDC Cayman (FRA:L74) Headlines

No Headlines